Albemarle Corporation (ALB) Fair Value 2026

ALB · Specialty Chemicals ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.2 /10

32 fundamental signals · 5 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-27, Albemarle Corporation (ALB) trades at $135.77, versus a $73.38 median fair value across its 5 active models — 46.0% below the current price. QOC: 7.2/10. Value Trap Risk: 24/100 (SAFE). 5/13 models active.

Key Facts

Ticker
ALB
Price
$135.77
Quality Score
7.2/10
Value Trap Risk
24/100
Models Active
5/13
Last Updated
Strength: 5 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Albemarle Corporation (ALB) Undervalued or Overvalued in 2026?

According to CirclFi’s 5-model valuation engine, Albemarle Corporation (ALB) appears overvalued as of : the median of 5 independent fair value estimates is $73.38, 46.0% below the current price of $135.77. Estimates range from $15.33 to $209.22. ALB scores 7.2/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. ALB’s -46.0% gap is wider than that market norm, and the Specialty Chemicals sector median is -35.9%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Albemarle Corporation Stock in 2026? →

What Fair Value Does Each Model Give ALB?

5 Intrinsic Value Models vs. Current Price ($135.77)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $73.38 -46.0%
Intrinsic · High Conviction
 $15.33 -88.7%
Unlock the Full Matrix

Access 3 additional models including Dynamic NAV, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is ALB's Fair Value Range?

Spread across 5 independent models · $15.33 to $209.22

CirclFi's 5 active models place Albemarle Corporation (ALB) between $15.33 and $209.22 per share, a spread of 264% of the median. The median of that range — $73.38 — is the fair value CirclFi publishes for ALB, against a current price of $135.77.

Low · ML-RIVHigh · Regime Cross
$15.33median $73.38$209.22
Where the range comes from
Most bearish modelML Residual Income$15.33
Most bullish modelRegime Cross-Sectional$209.22
Model agreement1 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for ALB. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on ALB, not a CirclFi price target. How each model works →

What Is Albemarle Corporation (ALB) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Albemarle Corporation's intrinsic value is estimated at $73.38, suggesting the stock is overvalued at its current price of $135.77. With 4 out of 5 models flagging downside (-46.0% vs price), the market may be pricing in unsustainable growth. The most optimistic model, Regime Cross, places fair value at $209.22 (+54.1%), while ML-RIV — the most conservative — estimates $15.33 (-88.7%). This +142.8% gap reflects genuine analytical uncertainty about Albemarle Corporation's intrinsic worth.

What Do the Models Say About ALB?

5 of 13 models are currently active for ALB. Of these, 1 model suggests upside while 4 models suggest overvaluation. Taken together, their median fair value for ALB is $73.38 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does ALB Rank in Specialty Chemicals?

Among 69 Specialty Chemicals stocks, ALB ranks #29 by Quality of Company score. CirclFi's QOC score of 7.2/10 evaluates 32 fundamental signals. A score of 7.2 indicates above-average quality.

See all Most Undervalued Specialty Chemicals Stocks →

Within the Specialty Chemicals space, Albemarle Corporation competes in an environment where order backlog depth often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ALB a Value Trap?

CirclFi's Value Trap algorithm assigns ALB a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for Albemarle Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Albemarle Corporation's fundamental quality profile registers 7.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +142.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ALB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ALB's 5 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Albemarle Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Specialty Chemicals Stocks Should You Also Analyze?

11 related Specialty Chemicals stocks with 13-model coverage

MTXMinerals Technologies Inc.QOC 7.2FSIFlexible Solutions International, Inc.QOC 7.2KWRQuaker Chemical CorporationQOC 7.3ALTOAlto Ingredients, Inc.QOC 7.2KOPKoppers Holdings Inc.QOC 7.4OECOrion S.A.QOC 7.0NNUPNocopi Technologies, Inc.QOC 6.3BIOFBlue Biofuels, Inc.QOC 4.1AXTAAxalta Coating Systems Ltd.QOC 8.6ODCOil-Dri Corporation of AmericaQOC 9.2RPMRPM International Inc.QOC 9.0

Read investment analysis: MTX · FSI · KWR · ALTO · KOP · OEC · NNUP · BIOF · AXTA · ODC · RPM

Which Other Stocks Have a Similar Quality Score to ALB?

7 companies across all industries closest to ALB’s Quality of Company score of 7.2/10.

AMPLAmplitude, Inc.QOC 7.2FATNFatPipe, Inc.QOC 7.2PTENPatterson-UTI Energy, Inc.QOC 7.2SPHRSphere Entertainment Co.QOC 7.2RRyder System, Inc.QOC 7.2NRUCNational Rural Utilities CooperQOC 7.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AMPL · FATN · PTEN · SPHR · R · NRUC · NVDA

Where Does ALB Sit in CirclFi's Specialty Chemicals Rankings?

ALB is ranked against every other Specialty Chemicals stock CirclFi covers in each of these screens.

See all Specialty Chemicals stocks ranked →

What Else Do Investors Ask About Albemarle Corporation’s Valuation?

What is Albemarle Corporation's intrinsic value in 2026?

CirclFi puts Albemarle Corporation (ALB)'s intrinsic value at $73.38 — the median of 5 independent model estimates as of 2026-08-27, ranging from $15.33 to $209.22. The Quality of Company score is 7.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ALB overvalued or undervalued right now?

At $135.77, 1 of 5 active models suggest ALB may be undervalued, while 4 indicate potential overvaluation. The median of all 5 fair value estimates is $73.38, 46.0% below the current price of $135.77 — a consensus view that ALB is overvalued. The assessment depends on which methodology best fits Albemarle Corporation's business model in Specialty Chemicals.

What does a Quality of Company score of 7.2 mean for ALB?

Albemarle Corporation's QOC of 7.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ALB?

CirclFi analyzes ALB with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on ALB?

Of the 5 models currently active on ALB, Regime Cross-Sectional is the most bullish at $209.22 per share, and ML Residual Income is the most bearish at $15.33. CirclFi's published fair value for ALB is the median of that range, $73.38, not either extreme. The gap between the two ends equals 264% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is ALB a value trap in 2026?

Albemarle Corporation's Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 5-model valuation engine, Albemarle Corporation (ALB) has a median fair value of $73.38 — 46.0% below the current price of $135.77 — as of 2026-08-27.” Source: circlfi.com/stock/ALB/ · Methodology
Primary sources for this ALB valuation
  • Financial statements: Albemarle Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0000915913) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ALB as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on ALB.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for ALB Unlock All 5 — $39/mo